Skip to main navigation
Skip to search
Skip to main content
Sort by
Pharmacology, Toxicology and Pharmaceutical Science
Proton Pump Inhibitor
100%
Allergic Asthma
50%
Antiallergic
50%
Ovalbumin
50%
Immunoglobulin E
50%
Lung Adenocarcinoma
50%
Chemotherapy
50%
Immune Checkpoint Inhibitor
50%
Chemotherapy Regimens
50%
Colorectal Carcinoma
50%
Diseases
37%
Carcinogen
25%
Capecitabine
23%
Interleukin 4
20%
Prostaglandin D2
20%
Interleukin 13
20%
Interleukin 6
20%
Overall Survival
17%
Progression Free Survival
17%
Cancer Staging
16%
Squamous Cell Carcinoma
13%
Dysbiosis
13%
Melanoma
13%
Renal Cell Carcinoma
13%
Transitional Cell Carcinoma
13%
Non Small Cell Lung Cancer
13%
Liver Cell Carcinoma
13%
Environmental Exposure
12%
Chromosomal Instability
12%
Biological Marker
12%
Lethality
12%
Mutagenic Agent
12%
Carcinogenesis
12%
Fluorouracil
11%
All Cause Mortality
11%
Cytokine
10%
Mouse
10%
Lung Disease
10%
Tumor Necrosis Factor
10%
Respiratory Tract Inflammation
10%
Antiinflammatory Activity
10%
Respiratory Tract Allergy
10%
Phosphotransferase Inhibitor
10%
Isoquinoline Alkaloid
10%
Receptor
10%
anthra[1,9 Cd]pyrazol 6(2h) One
10%
Phosphotransferase
10%
Disease
10%
Eosinophilia
10%
Histamine
10%
Immunology and Microbiology
Allergic Asthma
50%
Immunoglobulin E
50%
Mast Cell
50%
Cell Activation
50%
Bronchoalveolar Lavage Fluid
20%
Degranulation
20%
Amino Terminal Sequence
20%
Interleukin 6
20%
Bone Marrow Derived Mast Cell
20%
Interleukin 13
20%
Interleukin 4
20%
Prostaglandin D2
20%
Respiratory Tract Allergy
10%
Receptor Affinity
10%
Mouse
10%
Inflammatory Cell
10%
Histamine
10%
Tumor Necrosis Factor
10%
Body Weight
10%
Mediator
10%
Antiinflammatory Activity
10%
CD4
10%
Inflammatory Cytokine
10%
Interleukin 5
10%
Signal Transduction
10%
T Cell
10%
Nursing and Health Professions
Colorectal Carcinoma
50%
Proton Pump Inhibitor
50%
Chemotherapy
50%
Systematic Review with Meta-Analysis
50%
Capecitabine
23%
Fluorouracil
11%
All Cause Mortality
11%
Combination Therapy
7%
Medline
7%
